MedPharm to Expand its UK Analytical Service Labs
MedPharm’s £1.5-million (US$2.1-million) expansion of its Surrey, United Kingdom, facility will increase its UK laboratory space by 35% and enhance its topical and transdermal services.
MedPharm, a formulation development and analytical services company for topical and transdermal products, has invested £1.5 million (US$2.1 million) into the refurbishment and expansion of its 15,000-ft2 facility in Surrey, United Kingdom, increasing its UK laboratory space by 35%.
The expansion, which is set to be completed by the fourth quarter of 2021, will allow for a more efficient workflow and the ability for the company to continue to meet the demand for topical and transdermal services, MedPharm said in a May 20, 2021 company press release.
“We are excited to be renovating our formulation development and analytical laboratories, clinical manufacturing suites, and personnel workspace to ensure our operations and capabilities remain state of the art,” said Rob Turner, general manager UK, MedPharm, in the press release. “During the renovations, we will take extensive steps to de-risk the process and do not expect any disruption to our existing services, quality of scientific deliverables, and client commitments throughout the refurbishment.”
Source: MedPharm
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
